Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1

Conditions

Stomach Neoplasms 1Ovarian Neoplasms 1Lung Neoplasms 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Appendiceal Neoplasms 1

Interventions

Propofol 6Carboplatin 5Sevoflurane 4Saline Solution 3Paclitaxel 3Nivolumab 3Erlotinib Hydrochloride 3Acetaminophen 3Pemetrexed 2Midazolam 2Lidocaine 2Isoflurane 2Docetaxel 2Desflurane 2Cryotherapy 2Bupivacaine 2Bronchoscopy 2Anesthesia, Inhalation 2trametinib 1sotorasib 1pegfilgrastim 1icotinib 1endostar protein 1durvalumab 1dabrafenib 1capmatinib 1camrelizumab 1beta Carotene 1atezolizumab 1alectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Lung Neoplasms × Pafolacianine × Clear all
NCT07469202 2026-03-13

CYTALUX Dose Extension Study

On Target Laboratories, LLC

Phase 4 Not yet recruiting
106 enrolled
GynecologicThoracic

Lung Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡